Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

Back to Contracts

Safety Pharmacology (CNS, Cardiovascular, Pulmonary)

Active

Federal

Response Deadline08/18/2026, 07:00:00 PM UTC

Contract Overview

Solicitation details, issuing organization, response deadlines, documents, and interested companies for this government contract opportunity.

AI Contract Overview

Show more

The contract requires comprehensive safety pharmacology studies to evaluate adverse effects on the central nervous system, cardiovascular system, and pulmonary function, ensuring alignment with ICH safety guidelines. The work will involve detailed pharmacodynamic assessments to identify and characterize potential risks to major organ systems during early drug development, with a focus on identifying safety signals that could impact clinical translation. This subcontract, issued by the National Institutes of Health’s NIDA under the Department of Health and Human Services, is set to be performed in Bethesda and has a response deadline of August 18, 2026. The effort is classified under NAICS code 541711, indicating it pertains to research and development in the life sciences, and is aimed at supporting regulatory-compliant preclinical safety evaluations essential for pharmaceutical advancement.

General Info

Conduct safety pharmacology studies per ICH guidelines for CNS, cardiovascular, and pulmonary effects in Bethesda by August 18, 2026.

Agency

Department Of Health And Human Services → National Institutes Of Health NidaView Agency

NAICS

541711 - Research and Development in BiotechnologyView NAICS

Place of Performance

Bethesda, MD, USA

Set-Aside

NONE

Documents

(0)

No documents available

AI Contract Breakdown

Uniform Contract Format

No contract breakdown available.

Cannot generate Contract Breakdown because no documents were found from this contract's source.

Timeline

PostedAug 3

subcontract

Response DeadlineAug 18

Submission deadline

Response Deadline

08/18/2026, 07:00:00 PM UTCin 13 days

Ready to pursue this opportunity?

Start your free trial to track this contract, build proposals with AI assistance, and manage your pipeline.

Organization & Contact Information

Show more

AgencyDepartment Of Health And Human Services → National Institutes Of Health Nida

ContactsNo contacts available

OfficeN/A

Organization / Agency

Department Of Health And Human Services → National Institutes Of Health Nida

View Agency Profile

Office AddressN/A

ContactsNo contact information available

Full Description

Show more

Assess adverse pharmacodynamic effects on major organ systems including cardiovascular, CNS, and pulmonary functions to meet ICH safety guidelines.

Similar Contracts

Same NAICS industry code

In Vitro ADMET AssaysThe contract titled In Vitro ADMET Assays calls for the performance of high-throughput in vitro screening focused on metabolic stability, hepatotoxicity, CYP450 enzyme interactions, and cellular permeability to support early-stage drug development. These assays are critical for evaluating the absorption, distribution, metabolism, excretion, and toxicity profiles of potential therapeutic candidates, enabling informed decisions before advancing compounds into costly clinical stages. The work will be conducted to meet the specific needs of the National Institutes of Health NIDA under the Department of Health and Human Services, with performance expected to occur in Bethesda. This is a subcontract opportunity under NAICS code 541711, which classifies it as research and development in the physical, engineering, and life sciences. The solicitation was posted on August 3, 2026, with a response deadline of August 18, 2026, at 7:00 PM Eastern Time. There is no set-aside classification specified, and no point of contact or detailed office address is provided in the data. Interested parties must submit their proposals before the deadline to be considered for award, with the expectation that the selected contractor will deliver reliable, scalable, and scientifically rigorous ADMET data to guide NIDA’s research initiatives in drug development.

National Institutes Of Health Nida

POSTED

DEADLINE

Genotoxicity and Carcinogenicity TestingThe contract seeks to perform in vitro and in vivo assays to assess the mutagenic and carcinogenic risks of drug candidates, ensuring compliance with regulatory safety standards for pharmaceutical development. The work is critical for identifying potential genetic toxicity and cancer-causing properties early in the drug evaluation process to support regulatory submissions and public health safeguards. The solicitation is issued as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with performance expected to take place in Bethesda. It falls under the NAICS code 541711 for research and development in the physical, engineering, and life sciences. The proposal must be submitted by August 18, 2026, with the opportunity posted on August 3, 2026. No set-aside provisions are specified, and the contract is open to qualified subcontractors with the technical capacity to deliver high-quality genotoxicity and carcinogenicity testing services.

National Institutes Of Health Nida

POSTED

DEADLINE

Toxicity Testing (Acute, Subacute, Subchronic, Chronic)The contract requires the performance of comprehensive toxicity testing in both rodent and non-rodent models to assess organ toxicity and establish safety margins for submission to regulatory authorities as part of an Investigational New Drug application. The scope includes acute, subacute, subchronic, and chronic studies designed to evaluate the potential adverse effects of pharmaceutical compounds across a range of exposure durations and dosages. The work must meet rigorous scientific standards to support regulatory filings and ensure the safety profile of investigational drugs is adequately characterized prior to human trials. This subcontract is issued under the National Institutes of Health, National Institute on Drug Abuse, within the Department of Health and Human Services, with the performance location specified as Bethesda. The North American Industry Classification System code 541711 identifies the work as research and development in the life sciences. The solicitation was posted on August 3, 2026, with a mandatory response deadline of August 18, 2026, at 7:00 PM. No set-aside provisions are specified, and the contract opportunity is open to eligible contractors capable of executing preclinical toxicology studies to support IND submissions.

National Institutes Of Health Nida

POSTED

DEADLINE

In Vivo Pharmacokinetic StudiesThe contract seeks to perform in vivo pharmacokinetic studies to assess the absorption, distribution, metabolism, and excretion of a drug candidate in both rodent and non-rodent species across multiple administration routes, with the goal of generating data to support an Investigational New Drug application. These studies will evaluate drug exposure over time to establish pharmacokinetic profiles critical for regulatory submission, requiring rigorous experimental design, appropriate species selection, and adherence to good laboratory practices. All work must be completed to ensure high-quality, reproducible results that meet FDA expectations for preclinical development. The solicitation is classified as a subcontract under NAICS code 541711, issued by the National Institutes of Health through the National Institute on Drug Abuse, part of the Department of Health and Human Services. Performance is expected to take place in Bethesda, and interested parties must submit their responses no later than August 18, 2026, at 7:00 PM. The opportunity was posted on August 3, 2026, and is open for competitive bidding with no specific set-aside designation. The contract does not provide a point of contact, and all inquiries must be directed through the official SAM.gov portal linked in the posting.

National Institutes Of Health Nida

POSTED

DEADLINE

Influenza Vaccine Clinical Trial ManagementThe contract pertains to the design and management of Phase I–III clinical trials for influenza vaccines, encompassing all critical aspects from protocol development and site selection to patient recruitment and regulatory reporting to the FDA. The work requires specialized expertise in infectious disease trials, with a focus on ensuring compliance with regulatory standards and timely submission of clinical data. The performance location is in Washington, DC, with a zip code of 20024, indicating the primary operational base for trial oversight and coordination. This is a subcontract under the Department of Health and Human Services, specifically managed by Barda – ASPR / DAAPPO / Barda DCMA, with a NAICS code of 541711 indicating scientific research and development services. The opportunity was posted on July 30, 2026, with a response deadline of August 15, 2026, at 9:00 PM ET. While no set-aside type or point of contact is specified, the emphasis on end-to-end clinical trial management suggests the subcontractor must possess a proven track record in vaccine development, regulatory engagement, and multi-site trial execution under federal health security initiatives.

Barda - Aspr / Daappo / Barda Dcma

POSTED

DEADLINE

Clinical Trial Design and Efficacy Data GenerationThe contract calls for the design and execution of clinical trials aimed at evaluating the safety, wound closure, infection control, and functional regeneration outcomes of medical interventions in patients with burn and trauma injuries. The work requires rigorous scientific methodology to generate robust efficacy data that supports regulatory and clinical adoption, with a focus on measurable endpoints related to tissue recovery and patient outcomes. The trials must be conducted in accordance with established clinical standards and are intended to provide evidence of therapeutic effectiveness under real-world conditions. This is a subcontract under the Aspr Administration for Strategic Preparedness and Response, part of the Department of Health and Human Services, with a solicitation posted on July 28, 2026, and a response deadline of August 28, 2026. The work is classified under NAICS code 541711, indicating research and development in the life sciences. The performance location is designated with a zip code of 77416, though no specific city or state is provided, and no point of contact details are listed. The contract does not include a set-aside designation, and all eligible entities may respond, with emphasis placed on technical capability, trial design expertise, and experience in trauma and burn clinical research.

Aspr Administration For Strategic Preparedness And Response

POSTED

DEADLINE

Induced Pluripotent Stem Cell (iPSC) Reprogramming ServicesThe contract entails the reprogramming of human articular chondrocytes and bone marrow cells into induced pluripotent stem cells using Sendai virus technology, with full support for culture expansion and cryopreservation of the resulting iPSCs. This subcontract is part of a research initiative led by the Department of Veterans Affairs through Rpo East, focused on advancing regenerative medicine techniques through advanced cellular reprogramming methods. The work requires precise adherence to protocols ensuring high efficiency, safety, and scalability of iPSC generation while maintaining cell viability and pluripotency throughout the process. The solicitation is open for responses until August 6, 2026, and falls under NAICS code 541711, indicating it is for research and development in the biological sciences. The agreement is structured as a subcontract, suggesting it will be awarded to a specialized contractor with expertise in stem cell biology and virology-based reprogramming. Performance is expected to meet rigorous quality standards for cellular products intended for potential therapeutic or diagnostic applications, with an emphasis on reproducibility and documentation. All deliverables must include verified iPSC lines archived through cryopreservation, ready for downstream use in future studies or clinical translation.

Rpo East (36C24E)

POSTED

DEADLINE

in about 16 hours

Emerging Animal & Zoonotic Disease Diagnostics Research

Sci Technology Acq Division

POSTED

DEADLINE

Preclinical Animal Studies for Neurofibromatosis ResearchThe contract seeks to conduct preclinical in vivo studies using genetically engineered mouse models or alternative animal models of neurofibromatosis to assess the efficacy of therapeutic interventions, track tumor progression, and investigate underlying biological mechanisms. The work requires advanced expertise in animal modeling, tumor biology, and preclinical drug evaluation, with a focus on generating robust, reproducible data to support future clinical translation. All studies must be conducted in accordance with established ethical and scientific standards for animal research, with detailed documentation of methodologies, outcomes, and adverse events. This subcontract is issued under the Defense Health Agency Contracting Activity and falls under NAICS code 541711, indicating it supports research and development in the physical, engineering, and life sciences. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is open to qualified entities capable of executing complex preclinical studies. While the place of performance and point of contact details are unspecified, successful proposers must demonstrate capacity to manage animal facilities, comply with regulatory requirements, and deliver high-quality, timely results in support of neurofibromatosis research objectives under the Department of Defense.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Collaborative Biomedical Research ExecutionThis contract enables a collaborative biomedical research effort focused on neurofibromatosis, requiring coordinated hypothesis-driven investigations led by an Initiating Principal Investigator and a Partnering Principal Investigator. The work encompasses the design of experiments, generation of empirical data, and rigorous milestone-based progress reporting to ensure scientific rigor and accountability. The project is structured as a subcontract under the Defense Health Agency Contracting Activity, falling under the NAICS code for research and development in the physical, engineering, and life sciences, and is intended to advance understanding of neurofibromatosis through integrated scientific contributions. The solicitation was posted on June 25, 2026, with a response deadline of September 22, 2026, and is managed by the Department of Defense through its health research infrastructure. While no set-aside provisions or specific location details are provided, the emphasis is firmly on outcome-driven research with clearly defined deliverables tied to research milestones. The effort requires close alignment between the two principal investigators to ensure cohesive experimental planning, data integrity, and timely reporting, reflecting a strategic investment in translational medical science with potential implications for defense-relevant health conditions.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 1 month ago

DEADLINE

in about 2 months

Collaborative Research Partnership (Partnering PI Option)This contract establishes a collaborative research partnership where a Partnering Principal Investigator from an external institution will co-lead the research effort alongside the primary team, sharing equal responsibility for scientific direction, project management, and deliverables. Funding is jointly allocated between the participating institutions, ensuring aligned resources and mutual accountability for outcomes, with the work focused on health-related research under the Defense Health Agency Contracting Activity. The initiative falls under NAICS code 541711, indicating it is within the scientific research and development sector, and is structured as a subcontract to support integrated, multi-institutional innovation. The opportunity was posted on June 18, 2026, with a deadline for responses set for September 28, 2026, providing potential partners a defined window to submit proposals. The partnership is expected to be conducted in alignment with the mission of the Department of Defense, addressing critical health priorities through joint scientific leadership. There is no set-aside designation specified, meaning eligibility is open to qualified institutions regardless of size or status, and no specific location is designated for performance, allowing flexibility in where the research activities are carried out as long as the objectives are met collaboratively.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 2 months ago

DEADLINE

in about 2 months

Kidney Cancer Clinical Research ExecutionThe contract titled Kidney Cancer Clinical Research Execution aims to advance clinical and translational research focused on kidney cancer through comprehensive scientific activities including study design, patient data collection, biomarker analysis, and therapeutic development. The work is intended to support the development of innovative treatments and diagnostic strategies by integrating clinical observations with laboratory research, ensuring findings are rapidly translated into improved patient outcomes. The project requires expertise in oncology research methodologies, rigorous data management, and interdisciplinary collaboration to address critical gaps in kidney cancer understanding and care. This subcontract is issued by the Defense Health Agency Contracting Activity under the Department of Defense and falls under NAICS code 541711, indicating it is related to research and development in the life sciences. The opportunity was posted on June 18, 2026, with a response deadline of September 28, 2026, providing potential applicants approximately three months to prepare and submit proposals. The place of performance and specific office address details are not specified, suggesting flexibility in location but requiring proposers to align with the overarching objectives of the Department of Defense’s medical research priorities. All work must demonstrate scientific excellence, feasibility, and direct relevance to advancing kidney cancer therapeutics within a clinical context.

Defense Health Agency Contracting Activity - Dhaca

POSTED

about 2 months ago

DEADLINE

in about 2 months

More opportunities from Department Of Health And Human Services → National Institutes Of Health Nida

Same awarding agency

Transition and Continuity Planning ServicesThe contract titled Transition and Continuity Planning Services requires the development and execution of a detailed transition plan within seven days of award, ensuring seamless integration and operational readiness. Alongside this, a robust continuity plan must be established to safeguard uninterrupted operations during unforeseen disruptions or the loss of key personnel. The effort is subcontracted under the NAICS code 541611, aligned with management consulting services, and is sponsored by the National Institutes of Health NIDA within the Department of Health and Human Services. The proposal response deadline is August 11, 2026, and while no specific location is designated for performance, the work must support the agency’s operational continuity across all critical functions. The solicitation does not specify a set-aside type or point of contact, indicating a broad eligibility for qualified subcontractors.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Quality Assurance and Performance Surveillance SupportThe contract supports the development and execution of the Quality Assurance Surveillance Plan (QASP) for the National Institutes of Health NIDA, under the Department of Health and Human Services, with a focus on ensuring adherence to established performance metrics. Responsibilities include conducting monthly reporting, systematically tracking deficiencies, and maintaining compliance with all NIH quality and operational standards. The work requires close coordination to identify performance gaps and implement corrective actions in a timely manner to sustain service quality and regulatory alignment. This is a subcontract under NAICS code 541611 with a response deadline of August 11, 2026, and was posted on August 4, 2026. The place of performance and specific office address are not detailed, but the scope centers on quality assurance activities directly tied to NIH NIDA’s operational framework. Contractors must demonstrate expertise in performance surveillance, data-driven reporting, and compliance monitoring to meet the agency’s expectations for continuous improvement and accountability.

Administrative Management and General Management Consulting Services

POSTED

DEADLINE

Security Systems Operator Training and Certification ProgramThe contract titled Security Systems Operator Training and Certification Program requires the development and delivery of specialized training for contractor personnel on the National Institutes of Health’s security infrastructure, including intrusion detection systems, access control mechanisms, fire alarm systems, and video surveillance operations. The training must ensure that all personnel achieve certified competency in operating and maintaining these systems and include a robust certification tracking mechanism to verify compliance and proficiency. Refresher training sessions are mandated to maintain up-to-date knowledge and skills as protocols or technology evolve, ensuring continuous operational readiness and adherence to federal security standards. This subcontract, issued under NAICS code 611519 by the National Institutes of Health NIDA under the Department of Health and Human Services, is open for proposals with a response deadline of August 11, 2026, and was posted on August 4, 2026. The place of performance and specific location details are not provided, and no set-aside type is specified, meaning the contract is open to all eligible entities. The requirement emphasizes structured, ongoing education aligned with NIH’s critical security protocols, with accountability through certification records and recurrent training cycles to uphold the integrity and functionality of the agency’s physical security systems.

Other Technical and Trade Schools

POSTED

DEADLINE

24/7 Alarm Monitoring and Emergency Dispatch ServicesThe contract requires continuous 24/7 monitoring of intrusion detection, access control, fire alarm, and video surveillance systems across the NIH Bethesda Campus, ensuring real-time detection of security and safety incidents. The service provider must be capable of immediate emergency response execution, including the rapid dispatch of police, fire, and medical resources as needed, with full coordination and communication protocols in place to support campus safety. This service is critical for maintaining the security posture of a high-value federal research facility and demands unwavering reliability, rapid activation capabilities, and seamless integration with existing campus systems and emergency response teams. The contract is classified as a subcontract under NAICS code 561612 for alarm monitoring services and is solicited by the National Institutes of Health under the Department of Health and Human Services. It was posted on August 4, 2026, with a response deadline of August 11, 2026, and places the performance responsibility directly on the NIH Bethesda Campus. The scope demands technical proficiency in system monitoring, strict adherence to federal security standards, and the ability to operate under high-pressure conditions with zero tolerance for response delays. All services must be delivered around the clock with no interruption, and the provider must demonstrate proven experience in similar high-security environments.

Security Guards and Patrol Services

POSTED

DEADLINE

NIH Emergency Communications Services Support

Solicitation # 75N98026Q00949

The National Institutes of Health is seeking information from small businesses capable of providing 24/7/365 emergency communications services to support the Division of Emergency Management, specifically for Watch Officer and Security Control Center alarm monitoring functions. This includes continuous monitoring of intrusion detection, access control, fire alarm, and video surveillance systems, with staffing requirements of three personnel during daytime hours and two during nighttime hours to ensure uninterrupted coverage and immediate response to security incidents. The effort is critical to fulfilling compliance with 10 CFR 37.49 and safeguarding personnel, research assets, controlled materials, and critical infrastructure. The anticipated contract period spans five years, beginning September 15, 2026, with four optional one-year extensions through September 14, 2031. This sources sought notice is not a solicitation for proposals or quotes and does not obligate the government to award a contract; it is strictly for gathering market information to determine the appropriate acquisition strategy. The government is particularly interested in identifying qualified small businesses, including HUBZone, service-disabled veteran-owned, 8(a), veteran-owned, woman-owned, and small disadvantaged businesses, and requires respondents to confirm their size classification under NAICS code 561990. Responses must include a detailed capability statement addressing how the company meets the technical requirements, alongside business size status, DUNS number, organization details, and contact information for both technical and administrative points of contact. Submissions must be electronic, sent to Kevin Alvarez at kevin.alvarez@nih.gov, and received by August 11, 2026, at 9:00 a.m. Eastern Time. No proprietary, classified, or confidential information should be included, and the government reserves the right to use non-proprietary information in future solicitations. Respondents are cautioned that no feedback will be provided and no costs incurred in responding will be reimbursed.

All Other Support Services

POSTED

DEADLINE

Industrial Hygiene and Safety Support Services

Solicitation # 75N98026Q00948

The National Institutes of Health is seeking information from small business contractors to support the development of a future solicitation for Industrial Hygiene and Safety Support Services under NAICS code 541620. This notice is not a request for proposals or quotations but is intended to assess the availability, capacity, and size status of qualified small businesses capable of delivering essential occupational health and safety services. The services required include respiratory protection and fit testing, ergonomic evaluations, hazard and risk assessments, barrier oversight, and comprehensive radiation safety functions such as monitoring, surveys, instrument calibration, and compliance support for nuclear regulatory requirements. Responses must include a detailed demonstration of technical capability, business size classification under the NAICS code, and specific small business status such as HUBZone, 8(a), veteran-owned, woman-owned, or small disadvantaged business designation, along with organizational contact information and DUNS number. The anticipated contract period begins September 1, 2026, with base and two option years extending through August 31, 2029. The Division of Safety within the Office of Research Services requires these services to maintain regulatory compliance, safeguard personnel in research and clinical environments, and support the agency’s extensive intramural programs across 27 Institutes and Centers. All responses must be submitted electronically to Kevin Alvarez at kevin.alvarez@nih.gov by August 10, 2026, and must be presented in outline format addressing all requested elements. Respondents are warned that submissions will not be considered formal proposals, no award will result from this notice, and the government will not cover any costs incurred in preparing responses. Proprietary or classified information must not be included, as the government reserves the right to use non-proprietary details in future solicitations, and there is no obligation to acknowledge receipt or provide feedback on submissions.

Environmental Consulting Services

POSTED

DEADLINE

Regulatory Submission Support (IND-Enabling Package Assembly)The contract mandates the compilation, organization, and formatting of preclinical study data, protocols, and reports into fully integrated regulatory dossiers that meet the FDA’s electronic Common Technical Document requirements for Investigational New Drug submissions. This work involves ensuring all documentation is accurately structured, consistently formatted, and compliant with current regulatory standards to support the successful submission of IND packages. The contractor is expected to possess deep expertise in regulatory affairs, eCTD structure, and preclinical data management to deliver high-quality, audit-ready submissions on schedule. The task is issued as a subcontract under the National Institutes of Health NIDA, part of the Department of Health and Human Services, with performance based in Bethesda. The solicitation was posted on August 3, 2026, and responses are due by August 18, 2026. The North American Industry Classification System code 541690 indicates the work falls under other scientific and technical consulting services. There is no set-aside designation, and no specific point of contact is provided; all submissions must be made through the designated SAM.gov portal.

Other Scientific and Technical Consulting Services

POSTED

DEADLINE

Analytical Method Development and ValidationThe contract requires the development and validation of bioanalytical methods, including LC-MS/MS and ELISA, to accurately quantify drugs and their metabolites in biological matrices for use in pharmacokinetic and toxicology studies. These methods must meet industry standards for accuracy, precision, specificity, sensitivity, and reproducibility to ensure reliable data generation under regulatory expectations. The work is scoped to support preclinical and clinical research initiatives aimed at understanding drug behavior and safety profiles within biological systems. The contract is classified as a subcontract under NAICS code 541380, issued by the National Institutes of Health NIDA within the Department of Health and Human Services, with performance expected in Bethesda. The solicitation was posted on August 3, 2026, and responses are due by August 18, 2026. There is no set-aside designation specified, and the place of performance is restricted to Bethesda, indicating that all analytical work, data reporting, and validation documentation must be conducted on-site. While no point of contact is listed, applicants must ensure compliance with the technical scope, timelines, and quality benchmarks required to support NIH-funded research programs.

Testing Laboratories and Services

POSTED

DEADLINE